These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2355949)

  • 21. Lambert-Eaton myasthenic syndrome in childhood.
    Kostera-Pruszczyk A; Ryniewicz B; Rowinska-Marcinska K; Dutkiewicz M; Kamińska A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):194-6. PubMed ID: 18585938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cimetidine and transitory neutropenia in a patient with hemophilia (author's transl)].
    Sinco A; Conte G; Ambriz R; Avilés A; Morales MR; Pizzuto J
    Rev Invest Clin; 1981; 33(3):289-91. PubMed ID: 7330501
    [No Abstract]   [Full Text] [Related]  

  • 23. [Response to combined therapy with plasmapheresis and high doses of immunoglobulin in Lambert-Eaton syndrome].
    Díez-Tejedor E; Tejada J; Ramos MJ; Frank A; Cruz-Martínez A; Vivancos F; Barreiro P
    Neurologia; 1994 Feb; 9(2):76-7. PubMed ID: 8204254
    [No Abstract]   [Full Text] [Related]  

  • 24. [Lambert-Eaton syndrome without calcium channel autoantibodies].
    Delpont E; Martin-Moutot N; Brunetto JL; Desnuelle C
    Rev Neurol (Paris); 1994; 150(3):244-7. PubMed ID: 7863174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular complications of guanidine therapy in the myasthenic syndrome.
    Nakano KK; Tyler HR
    Neurology; 1970 Apr; 20(4):408. PubMed ID: 5535057
    [No Abstract]   [Full Text] [Related]  

  • 26. Congenital Lambert-Eaton myasthenic syndrome.
    Bady B; Chauplannaz G; Carrier H
    J Neurol Neurosurg Psychiatry; 1987 Apr; 50(4):476-8. PubMed ID: 3035103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decrement pattern in Lambert-Eaton myasthenic syndrome is different from myasthenia gravis.
    Baslo MB; Deymeer F; Serdaroglu P; Parman Y; Ozdemir C; Cuttini M
    Neuromuscul Disord; 2006 Jul; 16(7):454-8. PubMed ID: 16806929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eaton-Lambert syndrome: reflex improvement with guanidine.
    Oh SJ; Lee YW; Rutsky E
    Arch Phys Med Rehabil; 1977 Oct; 58(10):457-9. PubMed ID: 907453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebellar ataxia in non-paraneoplastic Lambert-Eaton myasthenic syndrome.
    Lorenzoni PJ; Scola RH; Lang B; Kay CS; Teive HA; Kowacs PA; Werneck LC
    J Neurol Sci; 2008 Jul; 270(1-2):194-6. PubMed ID: 18374949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lambert-Eaton myasthenic syndrome.
    D'Amour M; Gariepy G; Braidy J
    CMAJ; 2007 Jan; 176(1):37. PubMed ID: 17200388
    [No Abstract]   [Full Text] [Related]  

  • 31. Transient neutropenia and cimetidine.
    Souza Lima MS
    Gastroenterology; 1978 Jan; 74(1):162-3. PubMed ID: 618427
    [No Abstract]   [Full Text] [Related]  

  • 32. Lambert-Eaton myasthenic syndrome following varenicline (Chantix) use.
    Abou-Zeid E; Rudnicki SA; Keyrouz SG
    Muscle Nerve; 2009 Sep; 40(3):486-7. PubMed ID: 19697331
    [No Abstract]   [Full Text] [Related]  

  • 33. Synaptotagmin can cause an immune-mediated model of Lambert-Eaton myasthenic syndrome in rats.
    Takamori M; Hamada T; Komai K; Takahashi M; Yoshida A
    Ann Neurol; 1994 Jan; 35(1):74-80. PubMed ID: 8285596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Paraneoplastic myasthenic syndrome].
    Léger JM; Bachoud-Lévi AC; Eymard B; Théodore C; Bouche P; Pierrot-Deseilligny C
    Rev Neurol (Paris); 1993; 149(8-9):485-8. PubMed ID: 8009147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmune disorders of neuromuscular transmission.
    Mahadeva B; Phillips LH; Juel VC
    Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Lambert-Eaton myasthenic syndrome].
    Miyahara T; Kubo K; Kobayashi T; Sekiguchi M
    Ryoikibetsu Shokogun Shirizu; 1994; (4):13-6. PubMed ID: 8007106
    [No Abstract]   [Full Text] [Related]  

  • 37. The association of systemic lupus erythematosus and Lambert-Eaton myasthenic syndrome.
    Deodhar A; Norden J; So Y; Bennett R
    J Rheumatol; 1996 Jul; 23(7):1292-4. PubMed ID: 8823710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The potential use of ephedrine in Lambert-Eaton myasthenic syndrome : clinical and electrophysiological evaluation.
    Cereda C; Kuntzer T
    J Neurol; 2008 Aug; 255(8):1259-60. PubMed ID: 18535871
    [No Abstract]   [Full Text] [Related]  

  • 39. Cloning and characterization of a Lambert-Eaton myasthenic syndrome antigen.
    Rosenfeld MR; Wong E; Dalmau J; Manley G; Posner JB; Sher E; Furneaux HM
    Ann Neurol; 1993 Jan; 33(1):113-20. PubMed ID: 8494331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3,4-Diaminopyridine is more effective than placebo in a randomized, double-blind, cross-over drug study in LEMS.
    Oh SJ; Claussen GG; Hatanaka Y; Morgan MB
    Muscle Nerve; 2009 Nov; 40(5):795-800. PubMed ID: 19722254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.